Development Pipeline

Get AiViva Investor Brief
AiViva Pipeline Chart Updated 2022.v9 20230314 - FINAL

Development Candidates

cr=w_365,h_365

AIV001

Prolonged-Release Formulation For Intradermal Treatment

Find out more
rs=w_365,h_365,cg_true

AIV007

Gel Formulation Designed for Less Frequent Injection Regimen

Find out more
rs=w_365,h_365,cg_true (1)

JEL™ Technology

Proprietary technology that is customizable to optimize drug release and therapeutic effect

Find out more